Sartorius VZ: Demand is reviving. Morgan Stanley sees over 30% potential for the life sciences favorite!

Sartorius VZ (716563) is a leading provider of bioprocess solutions used in the production of biopharmaceuticals. The goal is to increase the efficiency of drug development and simplify production. This includes filtration and fermentation, as well as fluid management. The microbioreactor system Ambr 15 helps to determine the optimal production conditions and is thus important for process development. Laboratory products such as pipettes and scales are also marketed. Substantial investments were made during the COVID-19 pandemic. Consequently,...